Insulinomas derive from pancreatic beta-cells and are the most common form of functional neuroendocrine tumours of the pancreas with an incidence of 1-4 newly diagnosed cases per 1 million per year. Most are benign and have a diameter of less than 2 cm but in approximately 10% they are malignant (mostly in multiple endocrine neoplasia I patients) and metastasize, preferentially to lymph nodes and liver.

Resection is the therapy of choice and in many cases, the localization can be determined preoperatively.

However, the prognosis remains relatively poor with a 10-year survival of less than 30%.

Another cause of adult hyperinsulinemic hypoglycemia is adult beta cell hyperplasia for which the term “nesidioblastosis” has been resurrected that had been in use for CHI up to the 1980s. It is difficult to exactly determine the incidence of the disease, but it appears that in approximately 5% of the cases of adult hyperinsulinemic hypoglycaemia (AHH) nesidioblastosis may be the underlying pathology while insulinoma is responsible for the majority of cases.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline